Accuray Incorporated Free Cash Flow Per Share Over Time
| ARAY Stock | USD 2.07 0.02 0.96% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Accuray Incorporated Performance and Accuray Incorporated Correlation. Accuray |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accuray Incorporated. If investors know Accuray will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accuray Incorporated listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (0.17) | Revenue Per Share 4.478 | Quarterly Revenue Growth 0.168 | Return On Assets (0) |
The market value of Accuray Incorporated is measured differently than its book value, which is the value of Accuray that is recorded on the company's balance sheet. Investors also form their own opinion of Accuray Incorporated's value that differs from its market value or its book value, called intrinsic value, which is Accuray Incorporated's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accuray Incorporated's market value can be influenced by many factors that don't directly affect Accuray Incorporated's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accuray Incorporated's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accuray Incorporated is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accuray Incorporated's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Free Cash Flow Per Share Analysis
Compare Accuray Incorporated and related stocks such as SurModics, Axogen Inc, and Bioventus Free Cash Flow Per Share Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SRDX | 0.1044 | 0.8863 | 1.0886 | 1.1669 | 1.0088 | 1.3059 | 0.5794 | 1.5226 | 0.0963 | 0.7629 | 0.6618 | (1.4798) | 0.5414 | (0.2292) | (0.22) |
| AXGN | 0.11 | (1.9389) | (0.7926) | (0.7918) | (0.6233) | (0.5218) | (0.4037) | (0.316) | (0.659) | (3.6067) | (0.8062) | (1.0143) | (0.8868) | (0.4812) | (0.51) |
| BVS | (0.0648) | (0.0648) | (0.0648) | (0.0648) | (0.1028) | 0.2063 | 0.7034 | 0.7034 | 0.7034 | 0.5697 | 0.8997 | 0.2623 | (0.4082) | 0.1274 | 0.19 |
| CUTR | 1.0271 | (0.4287) | (0.1999) | 0.197 | (0.3522) | (0.1517) | 0.11 | 0.9682 | (0.0858) | (0.2276) | (1.0925) | 0.0123 | (4.7844) | (8.5934) | (8.16) |
| FNA | (0.0751) | (0.0751) | (0.0751) | (0.0751) | (0.0751) | (0.0751) | (0.0751) | (0.0751) | (0.0751) | (0.0751) | (0.1274) | (0.3219) | (1.2019) | (1.1198) | (1.18) |
| OFIX | 0.2558 | 2.1418 | (0.9257) | 1.9898 | 1.757 | 0.8154 | 1.4535 | 2.0087 | 1.8742 | 0.6088 | 2.9675 | (0.0567) | (1.7303) | (2.9351) | (2.79) |
| SIBN | (7.8167) | (7.8167) | (7.8167) | (0.5684) | (10.9403) | (1.2027) | (1.1107) | (1.2985) | (0.9724) | (1.3791) | (1.1433) | (1.3854) | (1.4959) | (0.6899) | (0.72) |
| AVNS | 2.1477 | 2.1477 | 3.4785 | 3.758 | 1.4913 | 0.5839 | 3.427 | 2.171 | (4.125) | (2.6282) | (0.4749) | 1.3784 | 1.5267 | 0.3133 | 0.3 |
| APYX | (0.0805) | 0.077 | (0.0334) | (0.1787) | (0.0592) | (0.2551) | (0.1138) | (0.1377) | (0.6441) | (0.5805) | (0.4866) | (0.3254) | (0.6168) | (0.167) | (0.18) |
| AORT | (0.3314) | 0.5179 | 0.5904 | 0.4625 | 0.1022 | 0.2645 | 0.386 | 0.114 | 0.1165 | 0.2089 | 0.1331 | (0.4021) | (0.3964) | 0.2797 | 0.29 |
| ANIK | (0.6056) | 0.6715 | 0.682 | 1.7551 | 2.6179 | 1.9981 | 0.6666 | 2.184 | 2.0954 | 2.4204 | 0.8042 | 0.226 | (0.2113) | (0.4923) | (0.47) |
| SGHT | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.4672) | (0.5489) | (0.7084) | (1.1231) | (1.6079) | (0.9866) | (1.04) |
| CTSO | (0.1613) | (0.6055) | (0.461) | (0.3925) | (0.4887) | (0.3879) | (0.2881) | (0.2947) | (0.4024) | (0.5667) | (0.1878) | (0.4218) | (0.7961) | (0.5059) | (0.53) |
| NPCE | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (1.0699) | (0.9095) | (1.0208) | (1.5236) | (0.7688) | (0.81) |
| CLPT | (19.5209) | (15.624) | (7.4912) | (5.5551) | (4.928) | (4.6235) | (2.1494) | (0.7778) | (0.4295) | (0.2288) | (0.523) | (0.6205) | (0.716) | (0.6003) | (0.63) |
| TELA | (2.5404) | (2.5404) | (2.5404) | (2.5404) | (2.5404) | (2.5404) | (2.5404) | (2.5404) | (3.3117) | (2.4741) | (1.9037) | (2.146) | (2.6199) | (1.8133) | (1.9) |
| KIDS | (1.7797) | (1.7797) | (1.7797) | (1.7797) | (1.7797) | (0.4185) | (0.7817) | (2.8567) | (1.6747) | (2.0415) | (1.652) | (1.5089) | (1.5357) | (2.0299) | (2.13) |
Accuray Incorporated and related stocks such as SurModics, Axogen Inc, and Bioventus Free Cash Flow Per Share description
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.My Equities
My Current Equities and Potential Positions
| Accuray Incorporated | ARAY |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.07
Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.